NCT02334098

Brief Summary

The objectives of this project are as follows:

  1. 1.To assess whether omega-3 dietary supplementation for six months can reduce externalizing behavior problems (antisocial and aggressive behavior) in schoolchildren aged 8 to 18, both at the end of treatment and six months post-treatment
  2. 2.To assess whether omega-3 supplementation is more effective in children with more psychopathic-like traits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Feb 2015

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 8, 2015

Completed
24 days until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

July 18, 2018

Status Verified

July 1, 2018

Enrollment Period

2.4 years

First QC Date

December 29, 2014

Last Update Submit

July 17, 2018

Conditions

Keywords

AggressionOmega-3 supplementationNeurocognitionAttentionAntisocial

Outcome Measures

Primary Outcomes (1)

  • Externalizing and internalizing behavior problems

    The following instruments will be administered to both caregivers and the children to assess child behavior behavior problems (externalizing and internalizing) Adolescent self-reported measures include Reactive-Proactive Aggression Questionnaire (RPQ), Antisocial Personality Screening Device (APSD), Conduct and Oppositional Defiant Disorder Questionnaire (COD) and Child Behavior Checklist (CBCL - Attention and Anxiety/Depressed subscales only).

    up to 12 months after initiation of trial: assessement at 0 months, 6 months (end of treatment) and 12 months (6 months post-tretament)

Secondary Outcomes (4)

  • Neurocognitive functioning

    up to 12 months

  • Psychophysiological functioning

    up to 12 months

  • Emotional empathy

    up to 12 months

  • Grit

    up to 12 months

Study Arms (3)

Omega-3 supplemented drink

EXPERIMENTAL

A 200 ml. drink product with 1.1 grams of omega-3 from Smartfish (Smartfish: Forsiden in Norway).

Dietary Supplement: Omega-3 supplemented drink

Placebo Drink

PLACEBO COMPARATOR

exactly the same fruit drink contained in the same packaging, but will contain no omega-3.

Dietary Supplement: Smartfish

treatment-as-usual controls

NO INTERVENTION

No drinks are taken.

Interventions

Omega-3 supplemented drinkDIETARY_SUPPLEMENT

The drink has apple/ pear/ pomegranate taste which is well accepted by children and adolescents, is rich in natural antioxidants to help prevent oxidation of omega-3. The drink can be taken at any time during the day. 1/3 of the participants will be assigned to the omega-3 group after randomization. They are going to take the treatment for 6 months. They will be assessed at baseline, end of treatment and 6 months post-treatment.

Omega-3 supplemented drink
SmartfishDIETARY_SUPPLEMENT

Treatment duration is 6 months. They will be assessed at baseline (0 months), end of treatment (6 months) and 6 months post-treatment (12 months).

Placebo Drink

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • children and adolescents between the age 8 and 18

You may not qualify if:

  • unwilling to participate in a randomized, double-blind, placebo controlled trial,
  • unable to give written, informed parental consent and assent from children,
  • on medication that may modify lipid metabolism in the past 3 months
  • significant use of omega-3 supplements in the past 6 months
  • seafood allergies
  • mental retardation
  • epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

City University of Hong Kong

Hong Kong, China

Location

MeSH Terms

Conditions

AggressionAntisocial Personality Disorder

Condition Hierarchy (Ancestors)

Aberrant Motor Behavior in DementiaBehavioral SymptomsBehaviorSocial BehaviorPersonality DisordersMental Disorders

Study Officials

  • Annis Fung, Ph.D.

    City University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
all participants and research assistants are blind to condition for the two fruit juice groups
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 3 parallel groups: (1) omega-3 + fruit juice (2) fruit juice only (3) controls (no drink).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 29, 2014

First Posted

January 8, 2015

Study Start

February 1, 2015

Primary Completion

July 1, 2017

Study Completion

July 1, 2018

Last Updated

July 18, 2018

Record last verified: 2018-07

Locations